Literature DB >> 21762290

Successful deep brain stimulation of the nucleus accumbens in severe alcohol dependence is associated with changed performance monitoring.

Jens Kuhn1, Theo O J Gründler, Robert Bauer, Wolfgang Huff, Adrian G Fischer, Doris Lenartz, Mohammad Maarouf, Christian Bührle, Joachim Klosterkötter, Markus Ullsperger, Volker Sturm.   

Abstract

Following recent advances in neuromodulation therapy for mental disorders, we treated one patient with severe alcohol addiction with deep brain stimulation (DBS) of the nucleus accumbens (NAc). Before and one year following the surgery, we assessed the effects of DBS within the NAc on the addiction as well as on psychometric scores and electrophysiological measures of cognitive control. In our patient, DBS achieved normalization of addictive behavior and craving. An electrophysiological marker of error processing (the error-related negativity) linked to anterior mid-cingulate cortex (aMCC) functioning was altered through DBS, an effect that could be reversed by periods without stimulation. Thus, this case supports the hypothesis that DBS of the NAc could have a positive effect on addiction trough a normalization of craving associated with aMCC dysfunction.
© 2011 The Authors, Addiction Biology © 2011 Society for the Study of Addiction.

Entities:  

Mesh:

Year:  2011        PMID: 21762290     DOI: 10.1111/j.1369-1600.2011.00337.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  36 in total

Review 1.  Neuromodulation interventions for addictive disorders: challenges, promise, and roadmap for future research.

Authors:  Primavera A Spagnolo; David Goldman
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

2.  Deep brain stimulation of the nucleus accumbens shell attenuates cocaine reinstatement through local and antidromic activation.

Authors:  Fair M Vassoler; Samantha L White; Thomas J Hopkins; Leonardo A Guercio; Julie Espallergues; Olivier Berton; Heath D Schmidt; R Christopher Pierce
Journal:  J Neurosci       Date:  2013-09-04       Impact factor: 6.167

Review 3.  Neuroimaging reward, craving, learning, and cognitive control in substance use disorders: review and implications for treatment.

Authors:  Jody Tanabe; Michael Regner; Joseph Sakai; Diana Martinez; Joshua Gowin
Journal:  Br J Radiol       Date:  2019-05-14       Impact factor: 3.039

Review 4.  Deep brain stimulation for the treatment of drug addiction.

Authors:  Tony R Wang; Shayan Moosa; Robert F Dallapiazza; W Jeffrey Elias; Wendy J Lynch
Journal:  Neurosurg Focus       Date:  2018-08       Impact factor: 4.047

5.  Electrical stimulation of the insular region attenuates nicotine-taking and nicotine-seeking behaviors.

Authors:  Abhiram Pushparaj; Clement Hamani; Wilson Yu; Damian S Shin; Bin Kang; José N Nobrega; Bernard Le Foll
Journal:  Neuropsychopharmacology       Date:  2012-11-15       Impact factor: 7.853

6.  Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction.

Authors:  J Kuhn; M Möller; J F Treppmann; C Bartsch; D Lenartz; T O J Gruendler; M Maarouf; A Brosig; U B Barnikol; J Klosterkötter; V Sturm
Journal:  Mol Psychiatry       Date:  2013-01-22       Impact factor: 15.992

7.  [Technical innovations in deep brain stimulation].

Authors:  J Vesper; P J Slotty
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

Review 8.  Brain Stimulation in Addiction.

Authors:  Michael C Salling; Diana Martinez
Journal:  Neuropsychopharmacology       Date:  2016-05-31       Impact factor: 7.853

9.  Advanced research on deep brain stimulation in treating mental disorders.

Authors:  Dongxin Wang; Xuejun Liu; Bin Zhou; Weiping Kuang; Tiansheng Guo
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

Review 10.  [Deep brain stimulation for addiction, anorexia and compulsion. Rationale, clinical results and ethical implications].

Authors:  C Bartsch; J Kuhn
Journal:  Nervenarzt       Date:  2014-02       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.